All results

1 results for phase 2 multi center double blind randomized dose ranging placebo controlled study

• Mino-Lok

  This is a Phase 3, multi-center, randomized, open-label, assess-blind study to determine the efficacy and safety of MLT, a novel antibiotic lock therapy that…

  Ages

  12 Years - N/A

  Sexes

  All